SAGE THERAPEUTICS INC's ticker is and the CUSIP is 78667J958. A total of 3 filers reported holding SAGE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $48,870 | -42.0% | 4,500 | 0.0% | 0.00% | – |
| Q1 2024 | $84,330 | +128.9% | 4,500 | +164.7% | 0.00% | – |
| Q4 2023 | $36,839 | -96.7% | 1,700 | -96.9% | 0.00% | -100.0% |
| Q3 2023 | $1,125,726 | +19.7% | 54,700 | +173.5% | 0.00% | +33.3% |
| Q2 2023 | $940,400 | +111.4% | 20,000 | +88.7% | 0.00% | +50.0% |
| Q1 2023 | $444,776 | -65.1% | 10,600 | -68.3% | 0.00% | -33.3% |
| Q4 2022 | $1,273,876 | +9.2% | 33,400 | +12.1% | 0.00% | +50.0% |
| Q3 2022 | $1,167,000 | -30.2% | 29,800 | -42.5% | 0.00% | -33.3% |
| Q2 2022 | $1,673,000 | -47.1% | 51,800 | -45.8% | 0.00% | 0.0% |
| Q1 2022 | $3,164,000 | +223.5% | 95,600 | +315.7% | 0.00% | +200.0% |
| Q4 2021 | $978,000 | -27.9% | 23,000 | -24.8% | 0.00% | 0.0% |
| Q3 2021 | $1,356,000 | -86.8% | 30,600 | -83.1% | 0.00% | -91.7% |
| Q2 2021 | $10,271,000 | +569.6% | 180,800 | +782.0% | 0.01% | +500.0% |
| Q1 2021 | $1,534,000 | -68.4% | 20,500 | -63.5% | 0.00% | -75.0% |
| Q4 2020 | $4,853,000 | +110.1% | 56,100 | +48.4% | 0.01% | +14.3% |
| Q3 2020 | $2,310,000 | +17.4% | 37,800 | -20.1% | 0.01% | -22.2% |
| Q2 2020 | $1,967,000 | +56.4% | 47,300 | +8.0% | 0.01% | -10.0% |
| Q1 2020 | $1,258,000 | -74.2% | 43,800 | -35.2% | 0.01% | -69.7% |
| Q4 2019 | $4,880,000 | -15.6% | 67,600 | +64.1% | 0.03% | -29.8% |
| Q3 2019 | $5,780,000 | -57.7% | 41,200 | -44.8% | 0.05% | -62.1% |
| Q2 2019 | $13,659,000 | +239.4% | 74,600 | +194.9% | 0.12% | +175.6% |
| Q1 2019 | $4,024,000 | +31.3% | 25,300 | -20.9% | 0.04% | +66.7% |
| Q4 2018 | $3,065,000 | +233.9% | 32,000 | +392.3% | 0.03% | +285.7% |
| Q3 2018 | $918,000 | -48.1% | 6,500 | -42.5% | 0.01% | -53.3% |
| Q2 2018 | $1,769,000 | -52.3% | 11,300 | -50.9% | 0.02% | -59.5% |
| Q1 2018 | $3,705,000 | -90.8% | 23,000 | -90.6% | 0.04% | -87.0% |
| Q4 2017 | $40,370,000 | +951.8% | 245,100 | +297.9% | 0.28% | +711.4% |
| Q3 2017 | $3,838,000 | -53.6% | 61,600 | -40.7% | 0.04% | -59.3% |
| Q2 2017 | $8,275,000 | +45.9% | 103,900 | +30.2% | 0.09% | +30.3% |
| Q1 2017 | $5,671,000 | +1723.5% | 79,800 | +1208.2% | 0.07% | +2100.0% |
| Q4 2016 | $311,000 | +57.1% | 6,100 | +41.9% | 0.00% | +50.0% |
| Q3 2016 | $198,000 | -45.3% | 4,300 | -64.2% | 0.00% | -50.0% |
| Q2 2016 | $362,000 | +2162.5% | 12,000 | +2300.0% | 0.00% | – |
| Q1 2016 | $16,000 | -94.9% | 500 | -93.2% | 0.00% | -100.0% |
| Q3 2015 | $313,000 | -62.4% | 7,400 | -35.1% | 0.00% | -66.7% |
| Q2 2015 | $832,000 | – | 11,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING LLC | 10,600 | $444,776 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 900 | $37 | 0.00% |